Fasting insulin vs A1c — which detects metabolic dysfunction earlier?
Fasting insulin moves first — often years before A1c. A1c is the standard diagnostic for diabetes, but fasting insulin (paired with fasting glucose as HOMA-IR) is the earliest sensitive marker of insulin resistance. The two answer different questions.
Full answer
Fasting insulin and hemoglobin A1c answer different questions. Fasting insulin reflects how hard the pancreas is working to keep glucose normal — it rises early in insulin resistance, often years (sometimes a decade) before A1c crosses any diagnostic threshold. A1c reflects average glycemia over the prior ~3 months and is the standard for diagnosing prediabetes and type 2 diabetes — but by the time A1c is elevated, the metabolic dysfunction has typically been progressing silently for a long time. For early detection in asymptomatic patients, fasting insulin (or, more precisely, the HOMA-IR derivation combining it with fasting glucose) is more sensitive. For diagnosis and ongoing monitoring of established dysglycemia, A1c remains the standard. Provider-reviewed wellness uses both, plus fasting glucose, because together they capture the full trajectory.
Educational. Not a substitute for individualized provider review.
- Fasting insulin — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29